TIA news stories

Home > TIA news stories

How TIA is helping to accelerate the development of Australian COVID-19 treatments

22 November 2022 No Comments

TIA supports bid to overcome leading cause of hospital ICU deaths

17 November 2022 No Comments

Developing a pain medication that doesn’t cause addiction

14 November 2022 No Comments

Virus and superbug vaccines at the core of TIA-supported research

31 October 2022 No Comments

Prescient Therapeutics Limited building LEGO-like solutions to address rapidly mutating cancers

24 October 2022 No Comments

Cancer medicine research advances with TIA expertise

20 September 2022 No Comments

National research infrastructure working together to improve the health of Australians

7 September 2022 No Comments

TIA partners with AAMRNet to accelerate therapeutic development research

25 July 2022 No Comments

NCRIS: The power behind Australia’s science

19 February 2022 No Comments

🏏 TIA reaches a century of voucher awards! 🏏

14 December 2021 No Comments

New role looks at worm saliva to eradicate diabetes

18 October 2021 No Comments

New Zealand accessing Australian expertise to build mRNA COVID-19 vaccines

16 September 2021 No Comments

Pipeline Navigator 2021-22 (Round 1) is now open for applications

31 August 2021 No Comments

Perkin Elmer and BIF collab to help train local businesses

27 July 2021 No Comments

Pipeline Accelerator 2020-21 (Round 2) Outcomes

6 July 2021 No Comments

2021 National Research Infrastructure Roadmap

4 June 2021 No Comments

trent munro linda lua and tim mercer

TIA’s investment in nucleic acid production

29 April 2021 No Comments

Boosting skills for future biologics industry

18 March 2021 No Comments

TIA Introductory Webinar

7 December 2020 No Comments

CSL signs agreement with Australian Government for UQ vaccine supply

7 September 2020 No Comments

Funding Boost for COVID-19 Research

13 August 2020 No Comments

Historic funding boost for Queensland’s fight against ovarian cancer

25 May 2020 No Comments

Positive outcome for Hendra antibody trial

4 February 2020 No Comments

New funding for biologics facility will keep research local

31 January 2020 No Comments

UQ antibody progresses to clinic with $20m investment

1 November 2019 No Comments

Contact us

TIA acknowledges and pays respects to the Traditional Custodians of the lands on which we and our facilities operate. We pay our respects to Elders, past, present and emerging and acknowledge the knowledge, traditions, and living cultures of Aboriginal and Torres Strait Islander peoples.

© 2023 Therapeutic Innovation Australia Ltd. Design by Juno Creative.